Developed mathematical model of Tf-DT intracellular trafficking pathway. Used model to predict drug efficacy and selectivity of mutant Tf-CRM107 conjugates. Validated predictions with in vitro cytotoxicity experiments. Mutant Tf-CRM107 exhibits improved efficacy. Mutant Tf-CRM107 exhibits good therapeutic index for cancer therapy.